Literature DB >> 7174693

Immunochemical heterogeneity of human plasma apolipoprotein B. I. Apolipoprotein B binding of mouse hybridoma antibodies.

L K Curtiss, T S Edgington.   

Abstract

Apolipoprotein B obtained from each of the major density classes of human plasma lipoproteins was investigated immunochemically. Eleven different mouse hybridoma cell lines were generated and selected on the basis of their ability to secrete antibodies that were bound by either very low density or intermediate density lipoproteins. Two of these antibodies appeared to be specific for complex epitopes on apoprotein B, since they were bound by all apoprotein B-containing lipoproteins, but not by apoprotein B after it had been delipidated and electrophoresed on sodium dodecyl sulfate-polyacrylamide gels. The remaining nine hybridoma antibodies were capable of binding to apoprotein B; and appeared to be specific for relatively simple epitopes that were expressed by denatured apoprotein B. The ability of these nine hybridoma antibodies to bind to the denatured apoprotein B species of plasma chylomicrons, very low density lipoproteins, and low density lipoproteins was compared. The apoprotein B species were separated on the basis of their relative mobility in low percentage sodium dodecyl sulfate-polyacrylamide gels and transferred to nitrocellulose paper for reaction with antibody. These binding studies suggest that plasma apoprotein B represents a complex family of immunochemically heterogeneous but related apoprotein species. A schematic summary of the apoprotein B species distribution of epitopes identified by these hybridoma antibodies is presented.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7174693

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Monoclonal antibody MB19 detects genetic polymorphism in human apolipoprotein B.

Authors:  S G Young; S J Bertics; L K Curtiss; D C Casal; J L Witztum
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

2.  Familial hypobetalipoproteinemia caused by a mutation in the apolipoprotein B gene that results in a truncated species of apolipoprotein B (B-31). A unique mutation that helps to define the portion of the apolipoprotein B molecule required for the formation of buoyant, triglyceride-rich lipoproteins.

Authors:  S G Young; S T Hubl; R S Smith; S M Snyder; J F Terdiman
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

3.  Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation.

Authors:  M F Linton; R Gish; S T Hubl; E Bütler; C Esquivel; W I Bry; J K Boyles; M R Wardell; S G Young
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

4.  Complement subcomponent C1q secreted by cultured human monocytes has subunit structure identical with that of serum C1q.

Authors:  A J Tenner; D B Volkin
Journal:  Biochem J       Date:  1986-01-15       Impact factor: 3.857

5.  Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteins.

Authors:  E S Krul; M J Tikkanen; T G Cole; J M Davie; G Schonfeld
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

6.  Genetic analysis of a kindred with familial hypobetalipoproteinemia. Evidence for two separate gene defects: one associated with an abnormal apolipoprotein B species, apolipoprotein B-37; and a second associated with low plasma concentrations of apolipoprotein B-100.

Authors:  S G Young; S J Bertics; L K Curtiss; B W Dubois; J L Witztum
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

7.  Chylomicron-retinyl palmitate clearance in type I hyperlipidemic families.

Authors:  D L Sprecher; S L Knauer; D M Black; L A Kaplan; A A Akeson; M Dusing; D Lattier; E A Stein; M Rymaszewski; D A Wiginton
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

8.  Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycans.

Authors:  Jon C Gonzales; Philip L S M Gordts; Erin M Foley; Jeffrey D Esko
Journal:  J Clin Invest       Date:  2013-05-08       Impact factor: 14.808

9.  Lipoproteins containing apoprotein B are a major regulator of neutrophil responses to monosodium urate crystals.

Authors:  R Terkeltaub; L K Curtiss; A J Tenner; M H Ginsberg
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

10.  A novel method for generating region-specific monoclonal antibodies to modified proteins. Application to the identification of human glucosylated low density lipoproteins.

Authors:  L K Curtiss; J L Witztum
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.